Seguir
MARIA PILAR INIESTA SERRANO
MARIA PILAR INIESTA SERRANO
Dirección de correo verificada de ucm.es
Título
Citado por
Citado por
Año
KRAS Mutations in Primary Colorectal Cancer Tumors and Related Metastases: A Potential Role in Prediction of Lung Metastasis
P Cejas, M Lopez-Gomez, C Aguayo, R Madero, J de Castro Carpeno, ...
PloS one 4 (12), e8199, 2009
1972009
Differential colorectal carcinogenesis: Molecular basis and clinical relevance
A Morán, P Ortega, C de Juan, T Fernández-Marcelo, C Frías, ...
World journal of gastrointestinal oncology 2 (3), 151, 2010
1582010
Correlations of telomere length, telomerase activity, and telomeric‐repeat binding factor 1 expression in colorectal carcinoma: Prognostic indications
C Garcia‐Aranda, C de Juan, A Diaz‐Lopez, A Sanchez‐Pernaute, ...
Cancer: Interdisciplinary International Journal of the American Cancer …, 2006
1262006
Telomere shortening is associated with poor prognosis and telomerase activity correlates with DNA repair impairment in non-small cell lung cancer
C Frías, C García-Aranda, C De Juan, A Morán, P Ortega, A Gómez, ...
Lung cancer 60 (3), 416-425, 2008
1242008
Inhibition of telomerase activity preferentially targets aldehyde dehydrogenase-positive cancer stem-like cells in lung cancer
D Serrano, AM Bleau, I Fernandez-Garcia, T Fernandez-Marcelo, ...
Molecular cancer 10, 1-15, 2011
1222011
Biological and clinical significance of MMP-2, MMP-9, TIMP-1 and TIMP-2 in non-small cell lung cancer
P Iniesta, A Morán, C De Juan, A Gómez, F Hernando, C García-Aranda, ...
Oncology reports 17 (1), 217-223, 2007
1002007
Clinical relevance of MMP-9, MMP-2, TIMP-1 and TIMP-2 in colorectal cancer
A Moran, P Iniesta, C Garcia-Aranda, C De Juan, A Díaz-López, ...
Oncology reports 13 (1), 115-120, 2005
892005
p53 exon 5 mutations as a prognostic indicator of shortened survival in non-small-cell lung cancer
FJ Vega, P Iniesta, T Caldes, A Sanchez, JA Lopez, C De Juan, ...
British journal of cancer 76 (1), 44-51, 1997
771997
MMP-7 and SGCE as distinctive molecular factors in sporadic colorectal cancers from the mutator phenotype pathway
P Ortega, A Moran, T Fernandez-Marcelo, C De Juan, C Frias, ...
International journal of oncology 36 (5), 1209-1215, 2010
752010
Clinical relevance of telomere status and telomerase activity in colorectal cancer
T Fernández-Marcelo, A Sánchez-Pernaute, I Pascua, C De Juan, J Head, ...
PloS one 11 (2), e0149626, 2016
692016
Expression of MMP-9 and TIMP-1 as prognostic markers in gastric carcinoma.
M de Mingo, A Morán, A Sanchez-Pernaute, P Iniesta, L Diez-Valladares, ...
Hepato-gastroenterology 54 (73), 315-319, 2007
612007
Telomere length and telomerase activity in non-small cell lung cancer prognosis: clinical usefulness of a specific telomere status
T Fernández-Marcelo, A Gómez, I Pascua, C de Juan, J Head, ...
Journal of experimental & clinical cancer research 34, 1-7, 2015
602015
Cooperative Role of Telomerase Activity and p16 Expression in the Prognosis of Non–Small-Cell Lung Cancer
R González-Quevedo, P Iniesta, A Morán, C de Juan, ...
Journal of clinical oncology 20 (1), 254-262, 2002
582002
Overexpression of SPARC protein contrasts with its transcriptional silencing by aberrant hypermethylation of SPARC CpG-rich region in endometrial carcinoma
FJ Rodríguez-Jiménez, T Caldés, P Iniesta, JA Vidart, JL Garcia-Asenjo, ...
Oncology reports 17 (6), 1301-1307, 2007
422007
Differential prognosis of replication error phenotype and loss of heterozygosity in sporadic colorectal cancer
MJ Massa, P Iniesta, R Gonzalez-Quevedo, C De Juan, T Caldes, ...
European Journal of Cancer 35 (12), 1676-1682, 1999
401999
Differential Wnt pathway gene expression and E-cadherin truncation in sporadic colorectal cancers with and without microsatellite instability
P Ortega, A Morán, C de Juan, C Frías, S Hernández, JA López-Asenjo, ...
Clinical cancer research 14 (4), 995-1001, 2008
382008
Comparative survival analysis of p53 gene mutations and protein accumulation in colorectal cancer
T Caldes, P Iniesta, FJ Vega, C de Juan, JA Lopez, E Diaz-Rubio, ...
Oncology 55 (3), 249-257, 1998
381998
Differential impact of p16 inactivation by promoter methylation in non-small cell lung and colorectal cancer: clinical implications
R González-Quevedo, C García-Aranda, A Morán, C De Juan, ...
International journal of oncology 24 (2), 349-355, 2004
362004
Stromelysin-1 promoter mutations impair gelatinase B activation in high microsatellite instability sporadic colorectal tumors
A Morán, P Iniesta, C de Juan, R González-Quevedo, ...
Cancer research 62 (13), 3855-3860, 2002
362002
Methylation profiling in non-small cell lung cancer: clinical implications
A Moran, T Fernandez-Marcelo, J Carro, C De Juan, I Pascua, J Head, ...
International journal of oncology 40 (3), 739-746, 2012
342012
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20